Lobular carcinoma in situ: A 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk

Journal of Clinical Oncology

Volumn 33, Issue 33, 2015, Pages 3945-3952

  King, Tari A ^a   Pilewskie, Melissa ^a   Muhsen, Shirin ^a   Patil, Sujata ^a   Mautner, Starr K ^a   Park, Anna ^a   Oskar, Sabine ^a   Guerini Rocco, Elena ^a   Boafo, Camilla ^a   Gooch, Jessica C ^a   De Brot, Marina ^a   Reis Filho, Jorge S ^a   Morrogh, Mary ^a   Andrade, Victor P ^a   Sakr, Rita A ^a   Morrow, Monica ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIBLIOGRAPHIC DATABASE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CANCER SURGERY; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LOBULAR CARCINOMA IN SITU; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; AGE; BREAST NEOPLASMS; CANCER CENTER; CANCER STAGING; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CASE CONTROL STUDY; DISEASE FREE SURVIVAL; EVALUATION STUDY; FACTUAL DATABASE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEW YORK; PARTIAL MASTECTOMY; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECONDARY PREVENTION; SURVIVAL ANALYSIS; TIME FACTOR; TREATMENT OUTCOME; TUMOR INVASION; TUMOR RECURRENCE; VERY ELDERLY;

TAMOXIFEN;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CANCER CARE FACILITIES; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEW YORK CITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SECONDARY PREVENTION; SURVIVAL ANALYSIS; TAMOXIFEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84948465029     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.61.4743     Document Type: Article

References (34)

1. Foote FW, Stewart FW: Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol 17:491-496, 1941
2. Haagensen CD, Lane N, Lattes R., et al: Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737-769, 1978
3. Rosen PP, Kosloff C, Lieberman P.H., et al: Lobular carcinoma in situ of the breast: Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2:225-251, 1978
4. Page DL, Schuyler PA, Dupont W.D., et al: Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: A retrospective cohort study. Lancet 361:125-129, 2003
5. Frykberg ER: Lobular carcinoma in situ of the breast. Breast J 5:296-303, 1999
6. Hussain M, Cunnick GH: Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast: A review. Eur J Surg Oncol 37:279-289, 2011
7. Page DL, Kidd TE Jr, Dupont WD, et al: Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22:1232-1239, 1991
8. Portschy PR, Marmor S, Nzara R., et al: Trends in incidence and management of lobular carcinoma in situ: A population-based analysis. Ann Surg Oncol 20:3240-3246, 2013
9. Page DL, Dupont WD, Rogers L.W., et al: Atypical hyperplastic lesions of the female breast: A long-term follow-up study. Cancer 55:2698-2708, 1985
10. Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146-151, 1985
11. Bodian CA, Perzin KH, Lattes R: Lobular neoplasia: Long term risk of breast cancer and relation to other factors. Cancer 78:1024-1034, 1996
12. Chuba PJ, Hamre MR, Yap J, et al: Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: Analysis of Surveillance, Epidemiology, and End Results data. J Clin Oncol 23:5534-5541, 2005
13. Degnim AC, Visscher DW, Berman H.K., et al: Stratification of breast cancer risk in women with atypia: A Mayo cohort study. J Clin Oncol 25:2671-2677, 2007
14. Ottesen GL, Graversen HP, Blichert-Toft M, et al: Lobular carcinoma in situ of the female breast: Short-term results of a prospective nationwide study - The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 17:14-21, 1993
15. Lakhani SR, Ellis IO, Schnitt S.J., et al: (eds): WHO Classification of Tumours of the Breast. Lyon, France, IARC Press, 2012
16. King TA, Muhsen S, Patil S., et al: Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat 142:445-453, 2013
17. Fisher ER, Land SR, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: Twelve-year observations concerning lobular carcinoma in situ. Cancer 100:238-244, 2004
18. Hartmann LC, Degnim AC, Santen R.J., et al: Atypical hyperplasia of the breast: Risk assessment and management options. N Engl J Med 372:78-89, 2015
19. Hartmann LC, Radisky DC, Frost M.H., et al: Understanding the premalignant potential of atypical hyperplasia through its natural history: A longitudinal cohort study. Cancer Prev Res (Phila) 7:211-217, 2014
20. London SJ, Connolly JL, Schnitt S.J., et al: A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941-944, 1992
21. Kabat GC, Jones JG, Olson N, et al: A multicenter prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control 21:821-828, 2010
22. Vogel VG, Costantino JP, Wickerham D.L., et al: Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer. Cancer Prev Res (Phila) 3:696-706, 2010
23. Goss PE, Ingle JN, Alés-Martinez JE, et al: Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364:2381-2391, 2011
24. Fisher B, Costantino JP, Wickerham D.L., et al: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371-1388, 1998
25. Cuzick J, Sestak I, Forbes J.F., et al: Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): An international, double-blind, randomised placebo-controlled trial. Lancet 383:1041-1048, 2014
26. Coopey SB, Mazzola E, Buckley J.M., et al: The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat 136:627-633, 2012
27. Visvanathan K, Hurley P, Bantug E., et al: Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31:2942-2962, 2013
28. Ropka ME, Keim J, Philbrick JT: Patient decisions about breast cancer chemoprevention: A systematic review and meta-analysis. J Clin Oncol 28:3090-3095, 2010
29. Roetzheim RG, Lee JH, Fulp W, et al: Acceptance and adherence to chemoprevention among women at increased risk of breast cancer. Breast 24:51-56, 2015
30. Andrade VP, Morrogh M, Qin L.X., et al: Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion. Mol Oncol 9:772-782, 2015
31. Andrade VP, Ostrovnaya I, Seshan V.E., et al: Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions. Breast Cancer Res 14:R103, 2012
32. Sakr RA, Scarpa JV, Schizas M, et al: Targeted capture next generation sequencing of fresh frozen lobular carcinoma in situ and invasive lobular cancer identifies a common repertoire of mutations. Cancer Res 74:927, 2014
33. Warner E, Messersmith H, Causer P., et al: Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148:671-679, 2008
34. Abdel-Fatah T.M., Powe DG, Hodi Z, et al: Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: Further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol 32:513-523, 2008